COVID-19 More Deadly with Blood than Solid Cancer: Study
COVID-19 More Deadly with Blood than Solid Cancer: Study
Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.
COVID-19 More Deadly with Blood than Solid Cancer: Study
COVID-19 More Deadly with Blood than Solid Cancer: Study

Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.

Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.

T cell
Cancer Vaccines: Raising a T Cell Army
Cancer Vaccines: Raising a T Cell Army
The Scientist Creative Services Team | Apr 1, 2021
Vaccines against various forms of cancer prime the immune system to attack.
Checking Checkpoints for Treating Cancer
Checking Checkpoints for Treating Cancer
The Scientist Creative Services Team | Mar 31, 2021
Researchers devise strategies to improve checkpoint inhibitor therapy and predict patient response.
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
The Scientist Staff | Mar 31, 2021
Researchers identify signatures that predict how a person will respond to an immune system stimulus.
Surveillance Gaps: How Cancer Arises
Surveillance Gaps: How Cancer Arises
The Scientist Creative Services Team | Mar 15, 2021
Surveillance Gaps: How Cancer Arises
Shifting Space and Time: How Harnessing Our Most Powerful Cells is Changing Immune Medicine
Shifting Space and Time: How Harnessing Our Most Powerful Cells is Changing Immune Medicine
The Scientist Creative Services Team | Dec 17, 2020
Industry and academic leaders will describe how small immune cell subsets shape the human immune response.
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Anthony King | Nov 11, 2020
Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
Doctors Consider Convalescent T Cell Therapy for COVID-19
Doctors Consider Convalescent T Cell Therapy for COVID-19
Abby Olena | Nov 6, 2020
Researchers propose that an infusion of memory T cells from people who have recovered from SARS-CoV-2 infections could treat severe disease.
Baking Soda Boosts T Cells’ Ability to Fight Leukemia
Baking Soda Boosts T Cells’ Ability to Fight Leukemia
Rachael Moeller Gorman | Nov 2, 2020
Infusions of donor T cells to fight the cancer often fail, but sodium bicarbonate can counter lactic acid produced by leukemia cells, potentially improving remission rates in mice and humans.
Investigating the Immune Response Using Advanced Flow Cytometry
Investigating the Immune Response Using Advanced Flow Cytometry
The Scientist Creative Services Team | Oct 8, 2020
Discover how researchers are using flow cytometry to delve into the inner workings of the immune life cycle!